EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:62913 - EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor
| ChEBI ID | CHEBI:62913 |
| ChEBI Name | EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor |
| Stars | |
| ASCII Name | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
| Definition | An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30). |
| Last Modified | 19 August 2024 |
| Submitter | Marcus Ennis |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) is a EC 2.4.2.* (pentosyltransferase) inhibitor (CHEBI:76790) |
| Incoming Relation(s) |
| 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide (CHEBI:177298) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| 2-{4-[(3R)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (CHEBI:177299) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| 3-aminobenzamide (CHEBI:64042) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| isoquinoline-1,5-diol (CHEBI:64044) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| ITK7 (CHEBI:231599) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| MC2050 (CHEBI:232977) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| mefuparib (CHEBI:167905) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| mefuparib hydrochloride (CHEBI:167899) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| nicotinamide (CHEBI:17154) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| niraparib (CHEBI:176844) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| NU 1025 (CHEBI:75399) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| olaparib (CHEBI:83766) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| phenanthridone (CHEBI:75292) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| PJ34 (CHEBI:167900) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| PJ34 hydrochloride (CHEBI:167904) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| rucaparib (CHEBI:134689) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| rucaparib camsylate (CHEBI:134692) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| veliparib (CHEBI:62880) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| Synonyms | Source |
|---|---|
| ADP-ribosyltransferase (polymerising) inhibitor | ChEBI |
| ADP-ribosyltransferase (polymerising) inhibitors | ChEBI |
| ADP-ribosyltransferase (polymerizing) inhibitor | ChEBI |
| ADP-ribosyltransferase (polymerizing) inhibitors | ChEBI |
| EC 2.4.2.30 inhibitor | ChEBI |
| EC 2.4.2.30 inhibitors | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| PARP_inhibitor | Wikipedia |